论文部分内容阅读
目的比较采用胰岛素泵连续皮下注射胰岛素(continuous subcutameous insulin injection,CSII)与每日多次皮下注射胰岛素(multi subcutaneous insulin injection,MSⅡ)对糖尿病脑卒中患者的血糖控制。方法CSⅡ组7例,采用胰岛素泵连续皮下注射诺和灵R。MSⅡ组7例,采用三餐前皮下注射诺和灵R和睡前注射诺和灵N。结果两组均能显著降低血糖水平。但血糖控制达到理想标准,CSⅡ组所需的治疗时间、胰岛素用量以及低血糖发生率均明显减少(P<0.05)。结论CSⅡ方法用于糖尿病脑卒中患者疗效好,安全性好,可更快、更有效地控制血糖,更能有效配合脑卒中病人治疗。
Objective To compare the glycemic control of diabetic stroke patients with continuous subcutameous insulin injection (CSII) and multi subcutaneous insulin injection (MS Ⅱ). Methods Seven patients in CS Ⅱ group were injected subcutaneously with Norenolone by insulin pump. In MSⅡgroup, 7 patients were given norepinephrine and Novolin N before bedtime before three meals. Results Both groups were able to significantly lower blood glucose levels. However, the blood glucose control reached the ideal standard. The treatment time, insulin dosage and the incidence of hypoglycemia in CSⅡ group were significantly decreased (P <0.05). Conclusion The CSⅡ method is effective and safe for stroke patients with diabetes. It can control blood sugar more quickly and effectively and is more effective in the treatment of patients with stroke.